Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
EmbeddedArt Group AB (publ) | EMART | Nov 22, 2024 | 7.20 | -9.43 |
Embellence Group | EMBELL | Nov 22, 2024 | 30.10 | -0.99 |
Embracer Group B | EMBRACB | Nov 22, 2024 | 27.55 | +0.18 |
Emilshus | EMILPREF | Nov 22, 2024 | 30.30 | +1.34 |
Emilshus B | EMILB | Nov 22, 2024 | 45.50 | +3.88 |
Enad Global 7 | EG7 | Nov 22, 2024 | 13.00 | 0.00 |
Enea | ENEA | Nov 22, 2024 | 97.60 | +1.88 |
Enersize | ENERS | Nov 22, 2024 | 0.01 | +1.28 |
Engcon AB | ENGCONB | Nov 22, 2024 | 117.40 | +2.80 |
Eniro Group | ENRO | Nov 22, 2024 | 0.46 | -1.50 |
Enorama Pharma | ERMA | Nov 22, 2024 | 3.77 | -2.33 |
Enrad | ENRAD | Nov 22, 2024 | 7.70 | 0.00 |
Envirologic B | ENVIB | Nov 22, 2024 | 16.25 | -5.80 |
Enzymatica | ENZY | Nov 22, 2024 | 1.80 | +3.45 |
Eolus Vind B | EOLUB | Nov 22, 2024 | 46.00 | -1.81 |
Ependion AB | EPEN | Nov 22, 2024 | 93.50 | +0.43 |
Epiroc A | EPIA | Nov 22, 2024 | 196.00 | +0.13 |
Epiroc B | EPIB | Nov 22, 2024 | 176.30 | +0.06 |
Episurf Medical B | EPISB | Nov 22, 2024 | 0.14 | -3.98 |
EQL Pharma | EQL | Nov 22, 2024 | 66.40 | 0.00 |
EQT | EQT | Nov 22, 2024 | 307.10 | +2.57 |
Ericsson A | ERICA | Nov 22, 2024 | 88.90 | +1.48 |
Ericsson B | ERICB | Nov 22, 2024 | 89.16 | +1.36 |
ES Energy Save Holding | ESGRB | Nov 22, 2024 | 29.45 | +1.38 |
Essity A | ESSITYA | Nov 22, 2024 | 303.00 | +1.51 |
Essity B | ESSITYB | Nov 22, 2024 | 302.20 | +1.10 |
Eurobattery Minerals | BAT | Nov 22, 2024 | 0.11 | -1.82 |
European Institute of Science B | EURIB | Nov 22, 2024 | 2.30 | 0.00 |
Everysport Group AB | EVERY | Nov 22, 2024 | 17.85 | +2.59 |
Evolear AB | EVOL | Nov 22, 2024 | 0.51 | +2.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.